{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:27:46Z","timestamp":1792528066277,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s13555-025-01586-w","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T06:33:42Z","timestamp":1763188422000},"page":"405-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["An Investigator-Blinded, Randomized Trial of a Broad-Spectrum Sunscreen Containing Sclareolide and Niacinamide for the Prevention of Post-inflammatory Hyperpigmentation in Skin of Color"],"prefix":"10.1007","volume":"16","clinical-trial-number":[{"clinical-trial-number":"isrctn11448711","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-6570","authenticated-orcid":false,"given":"Thierry","family":"Passeron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1271-310X","authenticated-orcid":false,"given":"Anthony","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3524-514X","authenticated-orcid":false,"given":"Marta","family":"Furmanczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Foyaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1925-5102","authenticated-orcid":false,"given":"Carles","family":"Trullas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4481-5602","authenticated-orcid":false,"given":"Jaime","family":"Piquero-Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"1586_CR1","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.2147\/CCID.S385162","volume":"15","author":"E Markiewicz","year":"2022","unstructured":"Markiewicz E, Karaman-Jurukovska N, Mammone T, Idowu OC. Post-inflammatory hyperpigmentation in dark skin: molecular mechanism and skincare implications. Clin Cosmet Investig Dermatol. 2022;15:2555\u201365.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1586_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1365-4632.2004.02267.x","volume":"43","author":"NL Lacz","year":"2004","unstructured":"Lacz NL, Vafaie J, Kihiczak NI, Schwartz RA. Postinflammatory hyperpigmentation: a common but troubling condition. Int J Dermatol. 2004;43:362\u20135.","journal-title":"Int J Dermatol"},{"key":"1586_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1473-2165.2008.00384.x","volume":"7","author":"A Taylor","year":"2008","unstructured":"Taylor A, Pawaskar M, Taylor SL, Balkrishnan R, Feldman SR. Prevalence of pigmentary disorders and their impact on quality of life: a prospective cohort study. J Cosmet Dermatol. 2008;7:164\u20138.","journal-title":"J Cosmet Dermatol"},{"key":"1586_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/pcmr.12692","volume":"31","author":"T Passeron","year":"2018","unstructured":"Passeron T, Nouveau S, Duval C, Cardot-Leccia N, Piffaut V, Bourreau E, et al. Development and validation of a reproducible model for studying post-inflammatory hyperpigmentation. Pigment Cell Melanoma Res. 2018;31:649\u201352.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"Suppl","key":"1586_CR5","first-page":"4","volume":"139","author":"G Cardinali","year":"2012","unstructured":"Cardinali G, Kovacs D, Picardo M. Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo. Ann Dermatol Venereol. 2012;139(Suppl):4.","journal-title":"Ann Dermatol Venereol"},{"key":"1586_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/1523-1747.ep12471536","volume":"89","author":"Y Tomita","year":"1987","unstructured":"Tomita Y, Iwamoto M, Masuda T, Tagami H. Stimulatory effect of prostaglandin E2 on the configuration of normal human melanocytes in vitro. J Investig Dermatol. 1987;89:299\u2013301.","journal-title":"J Investig Dermatol"},{"key":"1586_CR7","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/jid.2010.95","volume":"130","author":"BH Mahmoud","year":"2010","unstructured":"Mahmoud BH, Ruvolo E, Hexsel CL, Liu Y, Owen MR, Kollias N, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Investig Dermatol. 2010;130:2092\u20137.","journal-title":"J Investig Dermatol"},{"key":"1586_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/pcmr.12273","volume":"27","author":"L Duteil","year":"2014","unstructured":"Duteil L, Cardot-Leccia N, Queille-Roussel C, Maubert Y, Harmelin Y, Boukari F, et al. Differences in visible light-induced pigmentation according to wavelengths: a clinical and histological study in comparison with UVB exposure. Pigment Cell Melanoma Res. 2014;27:822\u20136.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1586_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158243","author":"F Bernerd","year":"2022","unstructured":"Bernerd F, Passeron T, Castiel I, Marionnet C. The damaging effects of long UVA (UVA1) rays: a major challenge to preserve skin health and integrity. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23158243.","journal-title":"Int J Mol Sci"},{"key":"1586_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105263","author":"C Marionnet","year":"2014","unstructured":"Marionnet C, Pierrard C, Golebiewski C, Bernerd F. Diversity of biological effects induced by longwave UVA rays (UVA1) in reconstructed skin. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0105263.","journal-title":"PLoS ONE"},{"key":"1586_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jid.2017.07.833","volume":"138","author":"C Regazzetti","year":"2018","unstructured":"Regazzetti C, Sormani L, Debayle D, Bernerd F, Tulic MK, De Donatis GM, et al. Melanocytes sense blue light and regulate pigmentation through Opsin-3. J Investig Dermatol. 2018;138:171\u20138.","journal-title":"J Investig Dermatol"},{"key":"1586_CR12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jid.2024.07.034","volume":"145","author":"E Yu","year":"2024","unstructured":"Yu E, Oh SW, Park S-H, Kwon K, Bin HS, Kang SH, et al. The pigmentation of blue light is mediated by both melanogenesis activation and autophagy inhibition through OPN3-TRPV1. J Investig Dermatol. 2024;145:908\u201318.","journal-title":"J Investig Dermatol"},{"key":"1586_CR13","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/bjd.15940","volume":"178","author":"I Kohli","year":"2018","unstructured":"Kohli I, Chaowattanapanit S, Mohammad TF, Nicholson CL, Fatima S, Jacobsen G, et al. Synergistic effects of long-wavelength ultraviolet al and visible light on pigmentation and erythema. Br J Dermatol. 2018;178:1173\u201380.","journal-title":"Br J Dermatol"},{"key":"1586_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s43630-025-00688-w","author":"SJ Mun","year":"2025","unstructured":"Mun SJ, Lee V, Gupta M. Sunscreens in pigmentary disorders: time to revise the message. Photochem Photobiol Sci. 2025. https:\/\/doi.org\/10.1007\/s43630-025-00688-w.","journal-title":"Photochem Photobiol Sci"},{"key":"1586_CR15","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jdv.18034","volume":"36","author":"L Duteil","year":"2022","unstructured":"Duteil L, Cadars B, Queille-Roussel C, Giraud I, Drulhon F, Graizeau C, et al. A new in vitro method to predict in vivo photoprotection of skin hyperpigmentation induced by visible light. J Eur Acad Dermatol Venereol. 2022;36:922\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1586_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2147\/CCID.S355329","volume":"15","author":"T Puaratanaarunkon","year":"2022","unstructured":"Puaratanaarunkon T, Asawanonda P. A randomized, double blinded, split-face study of the efficacy of using a broad spectrum sunscreen with anti-inflammatory agent to reduce post inflammatory hyperpigmentation after picosecond laser. Clin Cosmet Investig Dermatol. 2022;15:331\u20137.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1586_CR17","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1111\/jdv.12332","volume":"28","author":"R Wanitphakdeedecha","year":"2014","unstructured":"Wanitphakdeedecha R, Phuardchantuk R, Manuskiatti W. The use of sunscreen starting on the first day after ablative fractional skin resurfacing. J Eur Acad Dermatol Venereol. 2014;28:1522\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1586_CR18","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1080\/09546634.2021.1981814","volume":"33","author":"MG Tan","year":"2022","unstructured":"Tan MG, Kim WB, Jo CE, Nabieva K, Kirshen C, Ortiz AE. Topical treatment for postinflammatory hyperpigmentation: a systematic review. J Dermatol Treat. 2022;33:2518\u201326.","journal-title":"J Dermatol Treat"},{"key":"1586_CR19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.36849\/JDD.2020.4887","volume":"19","author":"A Shenoy","year":"2020","unstructured":"Shenoy A, Madan R. Post-inflammatory hyperpigmentation: a review of treatment strategies. J Drugs Dermatol. 2020;19:763\u20138.","journal-title":"J Drugs Dermatol"},{"key":"1586_CR20","first-page":"2518","volume":"33","author":"EC Davis","year":"2010","unstructured":"Davis EC, Callender V. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesth Dermatol. 2010;33:2518\u201326.","journal-title":"J Clin Aesth Dermatol."},{"key":"1586_CR21","unstructured":"Meyer I, Knupfer M, Le Maire M. Sclareolide, the natural active combating hyperpigmentation and spots. In: IFSCC conference 2015. 2015."},{"key":"1586_CR22","doi-asserted-by":"publisher","first-page":"e01366","DOI":"10.1016\/j.heliyon.2019.e01366","volume":"5","author":"P Filomena","year":"2019","unstructured":"Filomena P, Luca F, Ian H, Matteo B, El-magboub A, Angela F, et al. Naturally occurring sesquiterpene lactones and their semi-synthetic derivatives modulate PGE2 levels by decreasing COX2 activity and expression. Heliyon. 2019;5:e01366.","journal-title":"Heliyon."},{"key":"1586_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1046\/j.1365-2133.2002.04834.x","volume":"147","author":"T Hakozaki","year":"2002","unstructured":"Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147:20\u201331.","journal-title":"Br J Dermatol"},{"key":"1586_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/0278-6915(96)00029-4","volume":"34","author":"AP Walker","year":"1996","unstructured":"Walker AP, Basketter DA, Baverel M, Diembeck W, Matthies W, Mougin D, et al. Test guidelines for assessment of skin compatibility of cosmetic finished products in man. Food Chem Toxicol. 1996;34:651\u201360.","journal-title":"Food Chem Toxicol"},{"key":"1586_CR25","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00403-020-02071-4","volume":"312","author":"AB Lyons","year":"2020","unstructured":"Lyons AB, Kohli I, Nahhas AF, Braunberger TL, Mohammad TF, Nicholson CL, et al. Trichloroacetic acid model to accurately capture the efficacy of treatments for postinflammatory hyperpigmentation. Arch Dermatol Res. 2020;312:725\u201330.","journal-title":"Arch Dermatol Res"},{"key":"1586_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081123","volume":"389","author":"S Hopewell","year":"2025","unstructured":"Hopewell S, Chan A-W, Collins GS, Hr\u00f3bjartsson A, Moher D, Schulz KF, et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ. 2025;389:e081123.","journal-title":"BMJ"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01586-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01586-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01586-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:40:26Z","timestamp":1770190826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01586-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1586"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01586-w","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,15]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Thierry Passeron and Jaime Piquero-Casals serve as consultants for ISDIN. Anthony Brown, Carles Trullas, Marta Furmanczyk, and Monica Foyaca are employees of ISDIN.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study protocol (2023-A02785-40) was reviewed and approved by an appropriate IEC (Comit\u00e9 de Protection des Personnes (CPP) Ouest III) on 13 May 2024 and was conducted in accordance with the ethical principles initially outlined in the Declaration of Helsinki and its subsequent amendments and Good Clinical Practice (GCP). All subjects who participated in this clinical study were fully informed about the clinical study, and prior to inclusion, the subject and the investigator signed and dated the consent form(s).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}